pulseTV

VIDEO: Evaluation Tool for Neo-LVOT in Transcatheter Mitral Valve Procedures

Heart Valve Technology | May 20, 2019

A demonstration of how to calculate the neo-left ventricular outflow tract (neo-LVOT) on CT imaging for a transcatheter mitral valve replacement using Circle Imaging's advanced visualization software. The demonstration looks at the use of an Edward's Sapien valve being implanted for a mitral valve-in-valve procedure. The overhang of the Sapien can block the LVOT blood flow, which can be catastrophic for the patient. So, assessment of the neo-LVOT in a simulation of the implant is required prior to the procedure to find the ideal landing zone and assess if the patient's anatomy is compatible with this technique.  

Watch the related VIDEO: The Importance of the Neo-LVOT in Transcatheter Mitral Valve Replacement — an interview with Dee Dee Wang, M.D., director of structural heart imaging, Henry Ford Hospital. 

This clip was recorded on the expo floor at the 2018 Society of Cardiovascular Computed Tomography (SCCT).

 

Conference Videos

Heart Valve Technology | May 20, 2019

A demonstration of how to calculate the neo-left ventricular outflow tract (neo-LVOT) on CT imaging for a transcatheter mitral valve replacement using Circle Imaging's advanced visualization software. The demonstration looks at the use of an Edward's Sapien valve being implanted for a mitral valve-in-valve procedure. The overhang of the Sapien can block the LVOT blood flow, which can be catastrophic for the patient. So, assessment of the neo-LVOT in a simulation of the implant is required prior to the procedure to find the ideal landing zone and assess if the patient's anatomy is compatible with this technique.  

Watch the related VIDEO: The Importance of the Neo-LVOT in Transcatheter Mitral Valve Replacement — an interview with Dee Dee Wang, M.D., director of structural heart imaging, Henry Ford Hospital. 

This clip was recorded on the expo floor at the 2018 Society of Cardiovascular Computed Tomography (SCCT).

 

Cardiovascular Ultrasound | May 16, 2019

This is an example of how the heart's left atrial appendage (LAA) can be evaluated for thrombus and possible transcatheter occlusion using a new cardiac ultrasound lighting technology called TrueVue. It is a movable virtual light source that can interact with the echocardiography images to show photorealistic, virtual surgical views of the cardiac anatomy. The light source can be moved anywhere in the image, including behind structures to backlight them. The technology is offered on the Philips Healthcare Epiq CVx cardiovascular ultrasound system. It was shown for the first time in the U.S. at the American Society of Echocardiography (ASE) 2018 meeting.

See another VIDEO example of the photo-realistic lighting technology showing a transcatheter ASD closure with two Amplatzer occluders.

 

Stroke | May 16, 2019

This is an example of a carotid artery reporting module from Change Healthcare at 2018 Radiological Society of North America (RSNA) annual meeting. It shows how the PACS can bring in ultrasound imaging of the carotid artery and the graphical report can be modified to match the patient anatomy. The text and modifications made to the vessel tree convert into text to help auto-fill fields in the written report to help speed workflow. The vessel tree is similar to cath lab reporting systems that use a similar model of the coronaries that can be modified and helps auto complete the cath report.

 

Related Content:

VIDEO: What to Look for in PACS Workflow Efficiency

6 Key Health Information Technology Trends at HIMSS 2019

The Building Blocks of Enterprise Imaging

Technology Report: Enterprise Imaging

Find more RSNA 2018 coverage.

 

 

Information Technology | April 17, 2019

With Intellispace Enterprise Edition as the foundation, Philips Healthcare is connecting facilities and service areas within enterprises, while developing standards-based interoperability that preserves customers' investments and best of breed systems. 

Artificial Intelligence | April 17, 2019

Paul Chang, M.D., professor of radiology, vice chair of radiology informatics and medical director for enterprise imaging, University of Chicago, explains some of the issues with artificial intelligence (AI) and how hospitals can better prepare for its eventual implementation across the field medicine. A key takeaway is that hospitals need an infrastructure and roadway for AI and deep-learning algorithms to operate. Chang said most health systems will not invest directly in AI, but will invest in analytics, which Chang said uses much of the same infrastructure required by AI.

Chang spoke on this topic at an AIMed breakfast briefing seminar in Chicago April 9, 2019. Listen to a webcast of this hour and 15 minute talk.

 

 

 

Wearables | March 26, 2019

Khaldoun Tarakji, M.D., MPH, staff physician in the Section of Electrophysiology and Pacing in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute at the Cleveland Clinic, explains how wearable devices and smart phone apps can be used to aid electrophysiologists in patient care. He said the devices offer a constant remote monitoring of patient heart data, which can be helpful in diagnosing various types of arrhythmias and cardiac conditions. However, the main issue is how to sort through the large volumes of data and to figure out what the clinical value of some of this consumer data is through studies.  He spoke at the American College of Cardiology (ACC) 2019 meeting.

 

Other Cardiac Wearable Content:

VIDEO: Use of Wearable Medical Devices for Cardiac Rehabilitation — Interview with Robert Klempfner, M.D.

VIDEO: The Future of Wearables in Healthcare — Interview with Karl Poterack, M.D.

 

 

Cardiovascular Business | March 26, 2019

William Pinsky, M.D., a pediatric cardiologist and CEO of the Educational Commission for Foreign Medical Graduates (ECFMG), and Mandeep Mehra, M.D., medical director of the Brigham and Women’s Hospital (BWH) Heart and Vascular Center and professor of medicine at Harvard Medical School, explain the U.S. doctor shortage and how foreign doctors help fill the gap.

According to 2017 data provided by the Association of American Medical Colleges (AAMC), 40 percent of interventional cardiologists, 30 percent of cardiovascular disease specialists, and 26 percent of pediatric cardiologists in the United States are international medical graduates (IMGs). However, as the physician shortage continues to impact primary care doctors, psychiatrists, OB/GYNs, among others, the U.S. also expects to see a shortage of cardiologists within the next 10 years, according to a spotlight cardiology study issued by the professional services firm PYA, which specialized in healthcare consulting.

The interview was shot at the American College of Cardiology (ACC) 2019 meeting.

 

 

Cardio-oncology | March 22, 2019

Magid Awadalla, MBBS, is an advanced cardiac imaging research fellow at Massachusetts General Hospital. He has been involved in an imaging study of cardiac changes from photon radiotherapy in breast cancer patients using serial cardiac magnetic resonance imaging (MRI). The radiotherapy beams used to treat breast cancer pass close to the neighboring heart, which can cause cardiac cell damage leading to issues like heart failure later on. He spoke on the topic of cardio-oncology at the American College of Cardiology (ACC) 2019 meeting.

Nuclear Imaging | March 22, 2019

Raza Alvi, M.D., a research fellow in radiology at Massachusetts General Hospital, has been involved in a study of a positron-emission tomography (PET) FDG radiotracer agent to image sarcoidosis. The inflammatory disease affects multiple organs and usually include abnormal masses or nodules (granulomas) consisting of inflamed tissues that can form in the heart. Alvi presented on this topic at American College of Cardiology (ACC) 2019 meeting

 

Related Cardiac Sarcoidosis Content:

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis

New PET-CT Scan Improves Detection in Rare Cardiac Condition

25 Most Impactful Nuclear Cardiology Articles

Recent Advances in Cardiac Nuclear Imaging Technology

EP Lab | March 21, 2019

Khaldoun Tarakji, M.D., MPH, associate section head, section of electrophysiology and pacing in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute at the Cleveland Clinic. He presented the WRAP-IT late-breaking trial at the American College of Cardiology (ACC) 2019 meeting. The trial looked at the use of an antibacterial envelope for pacemakers and ICDs to reduce infection risk. 

Read the ACC.19 article Medtronic Tyrx Envelope Significantly Reduces Major Infections in Cardiac Implantable Device Patients.

 

Rlated EP video From ACC.19:

VIDEO: Key Trends in Electrophysiology — Apple Watch to Detect AF and the CABANA Trial — Interview with Christine Albert, M.D.

 

 

Wearables | March 08, 2019

Karl Poterack, M.D., medical director, applied clinical informatics, Mayo Clinic, explains the role wearable devices will play in healthcare. He presented in several sessions at the 2019 Healthcare Information Management and Systems Society at (HIMSS) conference.

Poterack said there is a brewing tsunami of data in wearable technologies that healthcare systems will have to figure out how to integrate in the coming years. He said the key issue with wearable data is that there needs to be outcomes data showing the value of how many steps a patient accumulates, changes in heart rate over time, or blood pressure changes in patients with specific aliments. Without this , he said there is limited value in the information. 

Watch the related VIDEO: Use of Wearable Medical Devices for Cardiac Rehabilitation.

Look through a photo gallery of other new technologies at HIMSS19. 

Find news and videos from HIMSS 2019.

Advanced Visualization | March 05, 2019

Augmented reality (AR) and virtual reality (VR) are starting to be adopted for physician training, patient education about their planned procedures, treatment planning and it is expected to be used as a procedure guidance tool in the near future. This example of AR displayed at the Healthcare Information Management and Systems Society (HIMSS) 2019 meetingwas among the most innovative because it allows users to "feel" the 3-D hologram of the heart. Developed by the company SoftServe., the “Touch My Heart” work-in-progress technology allows anyone wearing an AR headset to see and interact with the heart and get a touch sensation when they reach into the virtual tissue. A pad below the image is composed of dozens of ultrasound transducers that emit sound waves in the shape of the heart so users feel touch sensations when interacting with the virtual tissue.

Read the article "Virtual Reality Boosts Revenues and Patient Understanding,"

Look through a photo gallery of other new technologies at HIMSS19. 

Find news and videos from HIMSS 2019.

 

ECG | March 05, 2019

This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the Healthcare Information Management and Systems Society (HIMSS) 2019 meeting. It has a 3-D rendering of a patient showing where each lead needs to be placed. The user can rotate the images on the touch screen to see where the leads go and can easily identify where any issues are when the system automatically alerts them about misplaced leads. The goal is to improve and speed ECGs using a better form of visualization than the traditional black and white 2-D pictures. The system changes the lead place placements of the body rending based on the type of exam being performed using a drop down menu.

Look through a photo gallery of other new technologies at HIMSS19. 

Find news and videos from HIMSS 2019.

Artificial Intelligence | March 04, 2019

Anthony Chang, M.D., chief intelligence and innovation officer, Children's Hospital of Orange County (CHOC), and medical director of the Sharon Disney Lund Medical Intelligence and Innovation Institute. He is expert in artificial intelligence (AI). He spoke in several sessions at Healthcare Information and Management Systems Society (HIMSS) 2019 meeting on the integration of AI in healthcare. 

He said AI will play a big roll in imaging assessments of adult congenital heart disease to help relieve the burden on the small number of congenital cardiologists. 

Chang also explained there is a tsunami of data about to wash over healthcare as wearable devices begin to be integrated into patient care. AI will play a key role in sorting through all this data by monitoring the information to identify trends or disease markers and alert clinicians and the patient.

He was a keynote speaker at HIMSS19 with his session "Synergies Between Man and Machine — Future AI apps can be directed to help mitigate physician burnout by decreasing the EHR burden, improving medical education, and automating quality improvement."

Chang is head of the artificial intelligence organization AIMed, which hosts educational sessions and an annual meeting on AI applications in medicine.

Listen to Chang in the PODCAST: Fitting Artificial Intelligence Into Cardiology.
 

Read the article 6 Key Health Information Technology Trends at HIMSS 2019.

Look through a photo gallery of other new technologies at HIMSS19. 

Find news and videos from HIMSS 2019.

Wearables | February 28, 2019

Robert Klempfner, M.D., director of the Cardiovascular Prevention Institute, Sheba Medical Center, Israel,  discusses his center's use of wearable devices to manage a remote cardiac rehabilitation program. He spoke on the topic at 2019 Healthcare Information Management and Systems Society at (HIMSS) conference.   

Sheba Medical Center in Israel has adopted an app that interfaces with various wearables and Bluetooth-enabled patient monitoring devices to create remote cardiac rehabilitation and heart failure programs. It now remotely monitors hundreds of patients and does not require them to come to the hospital for sessions, which has helped increase patient satisfaction and aided in increasing physical activity compliance. The app is able to transfer device data to an EMR so progress and tasks assigned to patients can be monitored without the need for them to come into the hospital for sessions. Klempfner recently wrote a paper on this topic

Watch the related VIDEO: The Future of Wearables in Healthcare 

Look through a photo gallery of other new technologies at HIMSS19. 

Find news and videos from HIMSS 2019.

 

Wearables | February 28, 2019

How wearable devices will play a role in healthcare was a big topic at the Healthcare Information Management and Systems Society (HIMSS) 2019 meeting. The biggest question is how to attached the data from consumer devices into a usable format for clinicians that interfaces with the electronic medical record (EMR). A good example of how wearables are being integrated in clinical care was demonstrated by the company Datos. It offers software that can integrate data from a wide variety of wearable devices from several makers into a mobile app, It can transfer the information to an EMR. The app also offers two way communication between the patient and the doctor’s office. It can prompt patients with a list of things they need to do each day to reach physician specified goals and displays analytics on a patient’s health data, including charts and graphs.

The system is used by Sheba Medical Center in Israel for a remote cardiac rehabilitation program. It now remotely monitors hundreds of patients and does not require them to come to the hospital for sessions, which has helped increase patient satisfaction and aided in increasing physical activity compliance. Watch the VIDEO: Use of Wearable Medical Devices for Cardiac Rehabilitation — an interview with Robert Klempfner, M.D., director of the Cardiovascular Prevention Institute, Sheba Medical Center.
 

Look through a photo gallery of other new technologies at HIMSS19. 

Find news and videos from HIMSS 2019.

EP Lab | February 27, 2019

This is a virtual heart with the same electrophysiology characteristics as the real patient being developed to help optimize cardiac resynchronization therapy (CRT) lead placement. CRT currently has a 30 percent nonresponder rate, which is mainly due to the placement of leads. This model allows virtual placement of the leads In various locations to test response prior to the implantation procedure. The green dot shows the location of the virtual lead. It was unveiled at the Healthcare Information Management and Systems Society (HIMSS) 2019 annual meeting in February by Siemens. This "digital twin" technology is in development and will be able to create virtual, digital organs from a patient’s ECG, MRI scan and other clinical data. Siemens said the technology also might have applications for testing virtual ablations strategies to save procedure time when the patient is in the EP lab

Read more about the digital twin technology.

Look through a photo gallery of other new technologies at HIMSS19. 

Find news and videos from HIMSS 2019.

 

Enterprise Imaging | February 27, 2019

Steve Holloway, principal analyst and company director for the healthcare market research firm Signify Research, explains the key trends he is seeing in enterprise imaging systems. He spoke to ITN at the 2019 Healthcare Information Management and Systems Society at (HIMSS) conference.  

Additional HIMSS 2019 coverage.

Look through a photo gallery of new technologies highlighted at HIMSS 2019.

Watch the RSNA 2018 VIDEO: Technology Report — Enterprise Imaging

December 12, 2018

This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 Radiological Society of North America (RSNA) meeting.

This is a walk around of an innovative new SPECT-CT nuclear imaging system shown at the Radiological Society Of North America (RSNA) 2018 meeting this week. It's CT system with comes in 16, 64 or 128 slice configurations. It has 12 SPECT detector robotic arms that automatically move toward the patient and use a sensor to stop a few millimeters from the skin to optimize photon counts and SPECT image quality. It also uses more sensitive CZT digital detectors, which allows either faster scan times, or use of only half the radiotracer dose of analog detector scans.

Read the article “Nuclear Imaging Moves Toward Digital Detector Technology.” 

Read the article "Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition."

 

Cardiovascular Ultrasound | December 12, 2018

This is an example of the new Fetal HQ heart and vascular software from GE Healthcare for fetal ultrasound. The software, for the Voluson E10, helps evaluate the fetal heart shape, size and contractibility. A feature called Radiant Flow shows the blood flow in a 3-D view. It can also help show slow-flow blood, such as neuro-vascular circulation. This was shown for the first time at the 2018 Radiological Society of North America (RSNA) meeting.

 

Read more about this technology. 

 

Watch a VIDEO showing the fetal ventricular contractibility measures.

 

 

Cybersecurity | December 12, 2018

Anton S. Becker, M.D., radiology resident at the University Hospital of Zurich, Switzerland, discusses the long-term risks of cyberattacks on medical imaging data at the 2018 Radiological Society of North America (RSNA) annual meeting.

Advanced Visualization | December 12, 2018

This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at the Radiological Society Of North America (RSNA) 2018 meeting. It uses a HoloLens headset to register an overlay of the patient’s MR or CT scan in the patient. The operator can use hand movements to slice through and manipulate the images.

The vendor gained an FDA indication for AR to be used in surgical planning in 2018. NovaRad is working with the FDA for a second indication for use of the AR in the operating room during procedures.

This video is jerky, slightly misaligned and the hand movements did not always respond because itwas shot with an iPhone inside the visor. The image quality and hand movements are much better when actually wearing it on your head and aligned for the specific user.

Read more about this technology

Artificial Intelligence | December 12, 2018

This is an example of how artificial intelligence (AI) can help improve patient care by pulling together patient data from numerous sources n the elect if medical records that are specific to a patient’s diagnosis and treatment for a specific disease state. This is Siemens’ AI-Pathway Companion introduced at the Radiological Society Of North America (RSNA) 2018 meeting this week. In this examples. A prostate cancer patient has all their data on a single time line that can be accessed by single clicks on the points to open reports, images, procedures or labs.

At the end of the time line it integrates AI driven clinical decision support that recommends the next course of action based on clinical guidelines. The guidelines cited can also be opened for review by the clinician.

Cath Lab | November 15, 2018

Navin Kapur, M.D., discusses the results of the FDA STEMI Door-to-Unloading (DTU) safety and feasibility randomized controlled trial, presented as a late-breaking study at the 2018 American Heart Association meeting. Learn more at ProtectedPCI.com/DAIC.

 

Related Impella Video Content:

VIDEO: Complex PCI Involving Prior CABG and Comorbidities — Interview with Perwaiz Meraj, M.D.

VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device — Interview with William O'Neill, M.D.

VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael Amponsah, M.D.,

 

 

Heart Failure | November 15, 2018

James Januzzi, M.D., Hutter Family Professor at Harvard Medical School and a cardiologist at Mass General Hospital,, Boston, spoke at the 2018 American Heart Association (AHA) meeting about blood biomarkers that can aid in assessing reverse remodeling in heart failure patients with reduced ejection fraction (HFrEF). 

Januzzi mentions the use of high sensitivity troponin in this video. Watch a VIDEO interview with Januzzi on his research with high sensitivity troponin.

 

 

EP Lab | November 15, 2018

Wilber Su, M.D., chief of cardiac electrophysiology, Banner University Medical Center, Phoenix, and clinical associate professor of medicine at the University of Arizona, explains the Heart Rhythm Society (HRS) best practices document on cryoballoon ablation. He led the development of that document. He spoke at the 2018 American Heart Association (AHA) meeting.

Read the HRS "Best practice guide for cryoballoon ablation in atrial fibrillation: The compilation experience of more than 3,000 procedures."

Read the related article "New Technologies to Improve Atrial Fibrillation Ablation."

 

 

Artificial Intelligence | November 14, 2018

James Januzzi, M.D., Hutter Family Professor at Harvard Medical School and a cardiologist at  Mass General Hospital, Boston, spoke at the 2018 American Heart Association (AHA) meeting about his use of artificial intelligence to data-mine patient records. He spoke at AHA on the use of an AI-driven model to predict acute kidney injury (AKI) in patients undergoing coronary angiography, and on the results from a catheter sampled blood archive in a cardiovascular disease study.

Read the related article "How Artificial Intelligence Will Change Medical Imaging."

 

 

 

Computed Tomography (CT) | November 14, 2018

Matthew Budoff, M.D., professor of medicine, David Geffen School of Medicine, UCLA, spoke at the 2018 American Heart Association (AHA) meeting on the new AHA guidelines for cholesterol, including the use of computed tomography (CT) calcium scoring scans to assess patient risk. Budoff has been involved in several of the coronary artery calcium (CAC) trials that supported the new recommendation.

Read the related article "CT Calcium Scoring Becoming a Key Risk Factor Assessment."

 

 

Pharmaceuticals | November 13, 2018

Deepak L. Bhatt, M.D., executive director of the interventional cardiovascular program, Brigham and Women’s Hospital Heart & Vascular Center and Harvard Medical School, explains the results of the late-breaking REDUCE-IT Trial at the 2018 American Heart Association (AHA) meeting. This is a landmark study that showed icosapent ethyl (Vascepa) can significantly reduce major adverse cardiac and stroke events in patients with continued high triglyceride levels while on statin therapy.

Read the article on the REDUCE-IT Trial

Hypertension | November 07, 2018

Kim Allan Williams, Sr., M.D., chief of the Division of Cardiology and the James B. Herrick Professor at Rush University Medical Center, discusses the efforts being made by the Association of Black Cardiologists to reduce systemic hypertension in the African-American community. Williams is speaking on this topic at the American Heart Association 2018 meeting.

 

 

Cath Lab | November 07, 2018

In 2009, the GuideLiner Catheter revolutionized the concept of guide extension, creating new possibilities in interventional cardiology. Now in its third generation, the GuideLiner V3 Catheter continues to build on a history of innovation and performance — one that has been demonstrated with more than half a million catheters in cath labs around the world.

Teleflex also offers a family of Turnpike Catheters. These contain a robust multi-layer shaft that provides impressive flexibility, torque and tracking over a 0.014” guidewire in complex coronary and peripheral interventions. The unique five-layer composite shaft provides an ideal combination of flexibility and torque response to help navigate through complex anatomy while the outer polymer layer paired with a 60 cm distal hydrophilic coating facilitates smooth catheter delivery. This portfolio consists of the Turnpike Catheter (standard version), the Turnpike Spiral Catheter, the Turnpike Gold Catheter, and the Turnpike LP Catheter. Each catheter configuration contains a specific design element to address various clinical challenges in complex procedures

This year, Teleflex acquired two well-known PTCA balloon catheters. The Chocolate XD PTCA Balloon Catheter is a specialty angioplasty balloon, used in the pre-dilatation and treatment of coronary lesions. The balloon’s proprietary nitinol constraining structure creates “pillows” and “grooves” that are designed to provide controlled dilatation while minimizing vessel wall trauma.

The Glider PTCA Balloon Catheter is a semi-compliant balloon with a skived tip and low entry profile. The tip design, coupled with hydrophilic coating and an innovative, torqueable shaft, allows for precise tip orientation for use in crossing complex lesions and stent struts.

For more information: www.teleflex.com

Congenital Heart | November 01, 2018

Example of GE Healthcare’s FetalHQ software for the ultrasound imaging of fetal hearts. The new tool runs on GE Healthcare’s Voluson ultrasound systems and is the first tool to simultaneously examine the size, shape and function of the fetal heart echocardiography for congenital heart evaluations.

Read more about the technology in the article "Cardiac Ultrasound Software Streamlines Fetal Heart Exams."

 

 

October 11, 2018

Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific, explains key trial data presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference. He also explained the company's recent purchase of numerous start-up companies to expand in areas of structural heart, venous interventions, electrophysiology and oncology. 

Hear Meredith's insights in the VIDEO: Future Research and Development Efforts in Cardiovascular Medicine

 

October 11, 2018

A discussion with Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific, on future directions for cardiology device technology development. He spoke to DAIC at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference.

Hear Meredith's insights in the VIDEO: Boston Scientific's Recent Cardiology Advances and Technology Acquisitions

TCT | October 03, 2018

DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technology he found on the expo floor at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference.

Here are links to other Editor's Choice videos at recent conferences:

VIDEO: Editor's Choice of Most Innovative New Cardiac Technology at ACC 2018

VIDEO: Editor’s Choice of the Most Innovative Echo Technology at ASE 2018

VIDEO: Editor's Choice of the Most Innovative New Imaging Technology at RSNA 2017

 

 

#TCT2018

Overlay Init